The use of vasopressin receptor antagonists in hyponatremia-Reference-Cited by-同舟云学术

The use of vasopressin receptor antagonists in hyponatremia

Published:2011-02-14 Issue:3 Volume:20 Page:373-380
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Elhassan Elwaleed A¹,Schrier Robert W¹

Affiliation:

1. University of Colorado Denver, Division of Renal Diseases and Hypertension, Box C281, 12700 East 19th Avenue, Research 2, Room 7001, Aurora, CO 80045, USA ; ;

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.2011.553186

Reference47 articles.

1. Incidence and Prevalence of Hyponatremia

2. Age and gender as risk factors for hyponatremia and hypernatremia

3. Incidence, étiologies et facteurs pronostiques de l'hyponatrémie en réanimation

4. Impact of Hospital-Associated Hyponatremia on Selected Outcomes

5. Mild Hyponatremia Carries a Poor Prognosis in Community Subjects

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lixivaptan, a New Generation Diuretic, Counteracts Vasopressin-Induced Aquaporin-2 Trafficking and Function in Renal Collecting Duct Cells;International Journal of Molecular Sciences;2019-12-26

2. HIV/AIDS-related hyponatremia: an old but still serious problem;Renal Failure;2018-01-04

3. The V2 receptor antagonist tolvaptan raises cytosolic calcium and prevents AQP2 trafficking and function: an in vitro and in vivo assessment;Journal of Cellular and Molecular Medicine;2017-03-21

4. Characteristics of Persistent Hyponatremia and Tolvaptan Treatment in Nine Hospitalized Patients With Advanced HIV Disease;HIV Clinical Trials;2014-06

5. Global analysis of the effects of the V2 receptor antagonist satavaptan on protein phosphorylation in collecting duct;American Journal of Physiology-Renal Physiology;2014-02-15